Celularity Inc (CELU)

Sector:
FINANCE
Industry:
GENERAL FINANCE
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Robert J Hariri
Employees:
206
1325 AVENUE OF THE AMERICAS, 25TH FLOOR, NEW YORK, NY, 10019
2126163700

Celularity, headquartered in Florham Park, NJ, is a clinical-stage biotechnology company leading the next evolution in cellular medicine by developing off-the-shelf placental-derived allogeneic cell therapies, including unmodified natural killer (NK) cells, genetically-modified NK cells, T cells engineered with a CAR (CAR T-cells), and mesenchymal-like adherent stromal cells (ASCs) targeting indications across cancer, infectious and degenerative diseases. In addition, Celularity develops and manufactures innovative biomaterials also derived from the postpartum placenta. Celularity believes that by harnessing the placenta’s unique biology and ready availability, it will be able to develop therapeutic solutions that address significant unmet global needs for effective, accessible, and affordable therapies.

Data derived from most recent annual or quarterly report
Market Cap 969.193 Million Shares Outstanding123.464 Million Avg 30-day Volume 499.252 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-2.52
Price to Revenue0.0 Debt to Equity1.7648 EBITDA-206.814 Million
Price to Book Value0.0 Operating Margin0.0 Enterprise Value716.221 Million
Current Ratio EPS Growth-25.064 Quick Ratio
1 Yr BETA 0.8776 52-week High/Low 13.4 / 3.63 Profit Margin0.0
Operating Cash Flow Growth-5656.1578 Altman Z-Score Free Cash Flow to Firm 61.144 Million
Earnings Report2022-08-15
View SEC Filings from CELU instead.

View recent insider trading info

Funds Holding CELU (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CELU BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

HARIRI ROBERT J CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
8,250,724 2022-04-13 4

HAINES JOHN R SEE REMARKS

  • Officer
258,018 2022-04-13 4

GLOVER BRADLEY CHIEF TECHNOLOGY OFFICER

  • Officer
  • Director
77,407 2022-04-13 3

DUNN KEARY SEE REMARKS

  • Officer
64,505 2022-04-13 5

BEERS DAVID C CHIEF FINANCIAL OFFICER

  • Officer
161,262 2022-04-13 4

JONES ANNE CHIEF BUSINESS OFFICER

  • Officer
  • Director
64,505 2022-04-13 3

BRIGIDO STEPHEN PRES, FUNCTIONAL REGENERATION

  • Officer
129,010 2022-04-13 5

STARR INTERNATIONAL CO INC

STARR INTERNATIONAL INVESTMENTS LTD.

  • 10% Owner
15,281,389 2022-03-01 3

VON ESCHENBACH ANDREW C.

  • Director
307,437 2021-11-09 4

PECORA ANDREW L PRESIDENT

  • Officer
2,469,282 2021-09-15 2

MIRAKHUR BELOO EVP, CLINICAL DEVELOPMENT

  • Officer
125,000 2021-09-13 2

SCULLEY JOHN

  • Director
56,053 2021-09-09 3

KEHLER DEAN C

  • Director
56,053 2021-09-09 2

BLOOM JAY R

  • Director
56,053 2021-09-09 2

MAZUR MARC

  • Director
56,053 2021-09-09 2

SMITH ROBIN L

  • Director
56,053 2021-09-09 3

LIM KOK THAY

  • Director
56,053 2021-09-09 3

DIAMANDIS PETER

  • Director
56,053 2021-09-09 3

SORRENTO THERAPEUTICS, INC.

  • 10% Owner
20,422,124 2021-07-16 1

STARR INTERNATIONAL CO INC

  • 10% Owner
8,640,695 2021-07-16 3

GX SPONSOR LLC

  • 10% Owner
100,000 2021-07-16 1

DRAGASAC LTD

GENTING BERHAD

  • 10% Owner
30,062,778 2021-07-16 1

LEVY PAUL S

  • Director
0 2019-05-20 0

KELLETT ANDREA J. CHIEF FINANCIAL OFFICER

  • Officer
0 2019-05-20 0

MASELLI MICHAEL G VICE PRESIDENT OF ACQUISITIONS

  • Officer
0 2019-05-20 0

WEINBERGER HILLEL

  • Director
0 2019-05-20 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

DUNN KEARY - Officer SEE REMARKS

2022-04-28 21:04:29 -0400 2022-04-13 A 16,405 a 16,405 direct -0.4277 4.3627 4.3627 6 -2.6518 3

HAINES JOHN R - Officer SEE REMARKS

2022-04-28 21:06:19 -0400 2022-04-13 A 192,401 a 192,401 direct

JONES ANNE - Director - Officer CHIEF BUSINESS OFFICER

2022-04-28 20:52:54 -0400 2022-04-13 A 16,405 a 16,405 direct -0.4277 4.3627 4.3627 6 -2.6518 3

GLOVER BRADLEY - Director - Officer CHIEF TECHNOLOGY OFFICER

2022-04-28 20:55:12 -0400 2022-04-13 A 57,721 a 57,721 direct

HARIRI ROBERT J - Director - Officer CHIEF EXECUTIVE OFFICER

2022-04-28 21:05:45 -0400 2022-04-13 A 131,234 a 7,865,923 direct -0.4277 4.3627 4.3627 6 -2.6518 3

BRIGIDO STEPHEN - Officer PRES, FUNCTIONAL REGENERATION

2022-04-28 20:59:49 -0400 2022-04-13 A 96,201 a 96,201 direct

HAINES JOHN R - Officer SEE REMARKS

2022-04-28 21:06:19 -0400 2022-04-13 A 65,617 a 65,617 direct -0.4277 4.3627 4.3627 6 -2.6518 3

GLOVER BRADLEY - Director - Officer CHIEF TECHNOLOGY OFFICER

2022-04-28 20:55:12 -0400 2022-04-13 A 19,686 a 19,686 direct -0.4277 4.3627 4.3627 6 -2.6518 3

BEERS DAVID C - Officer CHIEF FINANCIAL OFFICER

2022-04-28 20:57:46 -0400 2022-04-13 A 120,251 a 120,251 direct

BRIGIDO STEPHEN - Officer PRES, FUNCTIONAL REGENERATION

2022-04-28 20:59:49 -0400 2022-04-13 A 32,809 a 32,809 direct -0.4277 4.3627 4.3627 6 -2.6518 3

DUNN KEARY - Officer SEE REMARKS

2022-04-28 21:04:29 -0400 2022-04-13 A 48,100 a 48,100 direct

JONES ANNE - Director - Officer CHIEF BUSINESS OFFICER

2022-04-28 20:52:54 -0400 2022-04-13 A 48,100 a 48,100 direct

BEERS DAVID C - Officer CHIEF FINANCIAL OFFICER

2022-04-28 20:57:46 -0400 2022-04-13 A 41,011 a 41,011 direct -0.4277 4.3627 4.3627 6 -2.6518 3

HARIRI ROBERT J - Director - Officer CHIEF EXECUTIVE OFFICER

2022-04-28 21:05:45 -0400 2022-04-13 A 384,801 a 384,801 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
CELULARITY INC CELU 2022-05-19 18:45:03 UTC -85.1883 86.0083 75000
CELULARITY INC CELU 2022-05-19 18:15:03 UTC -85.1883 86.0083 75000
CELULARITY INC CELU 2022-05-19 17:45:03 UTC -85.1883 86.0083 75000
CELULARITY INC CELU 2022-05-19 17:15:03 UTC -85.1883 86.0083 75000
CELULARITY INC CELU 2022-05-19 16:45:03 UTC -84.6838 85.5038 75000
CELULARITY INC CELU 2022-05-19 16:15:04 UTC -84.6838 85.5038 50000
CELULARITY INC CELU 2022-05-19 15:45:04 UTC -84.6838 85.5038 40000
CELULARITY INC CELU 2022-05-19 15:15:03 UTC -84.6838 85.5038 40000
CELULARITY INC CELU 2022-05-19 14:45:04 UTC -87.1364 87.9564 40000
CELULARITY INC CELU 2022-05-19 14:15:03 UTC -87.1364 87.9564 35000
CELULARITY INC CELU 2022-05-19 13:45:03 UTC -87.1364 87.9564 40000
CELULARITY INC CELU 2022-05-19 13:15:03 UTC -87.1364 87.9564 70000
CELULARITY INC CELU 2022-05-19 12:45:03 UTC -87.1364 87.9564 50000
CELULARITY INC CELU 2022-05-18 22:15:03 UTC -87.1364 87.9564 40000
CELULARITY INC CELU 2022-05-18 21:45:03 UTC -87.8783 88.6983 40000
CELULARITY INC CELU 2022-05-18 21:15:04 UTC -87.8783 88.6983 40000
CELULARITY INC CELU 2022-05-18 20:45:03 UTC -88.5518 89.3718 35000
CELULARITY INC CELU 2022-05-18 20:15:05 UTC -88.5518 89.3718 35000
CELULARITY INC CELU 2022-05-18 19:45:03 UTC -88.5518 89.3718 35000
CELULARITY INC CELU 2022-05-18 19:15:03 UTC -88.5518 89.3718 35000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments